GeoVax Labs, Inc.
GOVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000832489
No open-market purchases or sales by GeoVax Labs, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $625.5K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in GeoVax Labs, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +6 vs. Q2 2024
- Shares held
- 449.1K
- +282.3K (+169.2%) vs. Q2 2024
- Total value
- $1.08M
- +$551.0K (+103.7%) vs. Q2 2024
- New holders
- 8
- 1 more added
- Sold out
- 2
- 3 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GOVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $625.5K |
| Q1 2026 | 16 | $459.6K |
| Q4 2025 | 22 | $468.7K |
| Q3 2025 | 21 | $919.3K |
| Q2 2025 | 21 | $478.3K |
| Q1 2025 | 18 | $1.24M |
| Q4 2024 | 19 | $715.6K |
| Q3 2024 | 17 | $1.08M |
| Q2 2024 | 12 | $619.1K |
| Q1 2024 | 11 | $481.2K |
| Q4 2023 | 16 | $1.13M |
| Q3 2023 | 14 | $797.6K |
| Q2 2023 | 16 | $886.0K |
| Q1 2023 | 17 | $1.07M |
| Q4 2022 | 20 | $1.35M |
| Q3 2022 | 23 | $3.39M |
| Q2 2022 | 19 | $2.02M |
| Q1 2022 | 16 | $1.09M |
| Q4 2021 | 15 | $1.68M |
| Q3 2021 | 13 | $1.98M |
| Q2 2021 | 10 | $1.99M |
| Q1 2021 | 10 | $1.22M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding GeoVax Labs, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 266,000 | $641.1K | 0.00% | +266,000 | New |
| Geode Capital Management, LLC | 56,699 | $136.7K | 0.00% | +42,834+308.9% | Added |
| Virtu Financial LLC | 40,210 | $97.0K | 0.01% | +40,210 | New |
| BlackRock, Inc. | 27,565 | $66.4K | 0.00% | +27,565 | New |
| Two Sigma Investments, LP | 22,588 | $54.4K | 0.00% | +22,588 | New |
| Vanguard Group Inc | 19,239 | $46.4K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 11,608 | $28.0K | 0.00% | +11,608 | New |
| Tower Research Capital LLC (TRC) | 2,991 | $7.21K | 0.00% | −4,265−58.8% | Reduced |
| UBS Group AG | 1,141 | $2.75K | 0.00% | +1,141 | New |
| Morgan Stanley | 762 | $1.84K | 0.00% | −642−45.7% | Reduced |
| Wells Fargo & Company | 134 | $323 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 43 | $104 | 0.00% | −44,729−99.9% | Reduced |
| Global Retirement Partners, LLC | 27 | $65 | 0.00% | 00.0% | Unchanged |
| Duncker Streett & Co Inc | 24 | $58 | 0.00% | +24 | New |
| FMR LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 4 | $0 | 0.00% | 00.0% | Unchanged |
| AlphaMark Advisors, LLC | 50 | $0 | 0.00% | +50 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |